GH
TEVA icon

GAM Holding’s Teva Pharmaceuticals TEVA Stock Holding History

GAM Holding’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-23,000
Closed -$393K – 968
2018
Q1 		$393K Sell
23,000
-2,600
-10% -$50.8K 0.01% 700
2017
Q4 		$485K Sell
25,600
-1,182
-4% -$17.8K 0.01% 746
2017
Q3 		$471K Sell
26,782
-15,118
-36% -$340K 0.02% 436
2017
Q2 		$1.39M Buy
41,900
+7,900
+23% +$245K 0.02% 570
2017
Q1 		$1.09M Buy
+34,000
New +$1.16M 0.02% 634
2016
Q3 		– Sell
-1,724
Closed -$87K – 969
2016
Q2 		$87K Sell
1,724
-3,901
-69% -$208K ﹤0.01% 928
2016
Q1 		$301K Sell
5,625
-31,567
-85% -$1.85M 0.01% 776
2015
Q4 		$2.44M Sell
37,192
-6,625
-15% -$409K 0.04% 447
2015
Q3 		$2.47M Sell
43,817
-87,821
-67% -$5.69M 0.04% 421
2015
Q2 		$7.78M Sell
131,638
-314,849
-71% -$19.4M 0.11% 203
2015
Q1 		$27.8M Buy
446,487
+237,334
+113% +$13.8M 0.42% 57
2014
Q4 		$12M Sell
209,153
-18,347
-8% -$1.02M 0.18% 149
2014
Q3 		$12.2M Sell
227,500
-40,100
-15% -$2.12M 0.18% 153
2014
Q2 		$14M Sell
267,600
-8,880
-3% -$454K 0.21% 133
2014
Q1 		$14.6M Buy
276,480
+26,597
+11% +$1.23M 0.23% 125
2013
Q4 		$10M Buy
249,883
+41,863
+20% +$1.65M 0.17% 158
2013
Q3 		$7.86M Sell
208,020
-14,200
-6% -$554K 0.15% 175
2013
Q2 		$8.71M Buy
+222,220
New +$8.65M 0.19% 150

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

GAM Holding's TEVA Position: Q2 2018 in Review

GAM Holding sold out of Teva Pharmaceuticals (TEVA) in Q2 2018, closing a stake of 23,000 shares — an estimated $393K sold.

GAM Holding first reported a position in TEVA in Q2 2013 and held it in 18 quarters. The position peaked at $27.8M in Q1 2015. 539 funds tracked by Wall St. Rank hold TEVA as of Q2 2018.

  • GAM Holding reported no remaining Teva Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
  • GAM Holding sold 23,000 Teva Pharmaceuticals shares in Q2 2018, an estimated $393K.
  • GAM Holding first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 18 quarters.
  • GAM Holding's Teva Pharmaceuticals position peaked at $27.8M in Q1 2015.
  • 539 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2018.

Based on GAM Holding's 13F filing for Q2 2018, filed 9 Aug 2018.